Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pulmonology
•
Pulmonary Hypertension
•
Diffuse Parenchymal Lung Disease
•
General Pulmonary
What strategies are effective for managing cough in patients receiving inhaled treprostinil?
Related Questions
Do you utilize cytokine panels to guide treatment of patients with EGPA?
Are there benefits to adding IL5/IL5 receptor blockade in patients with vasculitic manifestations of EGPA?
What is the duration of steroids that you prescribe for organizing pneumonia?
Are there certain clinical features that help you choose between benralizumab and mepolizumab for EGPA in clinical practice?
What are your vaccine recommendations while patients are on biologics?
Do you have any strategies to increase yield while doing a BAL?
What factors would encourage you to choose abatacept vs tocilizumab in a patient with RA-ILD with a UIP pattern of pulmonary fibrosis?
Do you recommend air purifier in bedrooms and office/workplaces of patients with chronic lung disease?
What is the role of inebilizumab in the maintenance treatment of IgG4-related disease?
How do you plan to integrate nerandomilast into the treatment algorithm for patients with ILD?
